Trial Profile
Efficacy and Safety of Chiauranib in Advanced Hepatocellular Carcinoma: a Single-arm, Open-label, Multi-center, Exploratory Phase Ib Study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Ibcasertib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Chipscreen Biosciences
- 15 Jun 2021 Status changed from recruiting to completed.
- 29 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 29 Jan 2019 Planned primary completion date changed from 1 Jul 2018 to 1 Jul 2019.